Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
- Status
- UNKNOWN
- Phase
- NA
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Brain Mets - Capecitabine Plus Sunitinib and WBRT
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3